Home Certificates of analysis TA110-0803
Certificate of analysis
Thymosin alpha-1 10 mg
Lot TA110-0803 · certificate issued Aug 28, 2026
Latest certificate
Verified · COA7585Purity
99.78%
RP-HPLC (214 nm)
Measured content
10.87 mg
Stated strength 10 mg
Sterility
Not Detected
USP <71>
All results
| Test | Result | Method |
|---|---|---|
| Purity | 99.78% | RP-HPLC (214 nm) |
| Measured content | 10.87 mg | HPLC quantitation |
| Identity | Conforms | LC-MS/MS |
| Endotoxin | <0.05 EU/ml | USP <85> |
| Heavy metals | <0.01 ppm | USP <232> |
| Sterility | Not Detected | USP <71> |
Values as printed on the laboratory’s certificate. Where a certificate does not list a result, this page says so and fills nothing in.
Certificate & verification details
Verification number
COA7585Checked Sep 24, 2026: this number opens this certificate on the testing laboratory’s own site.
- Testing laboratory
- Bioviridian Inc. · signed by Shane Straight, M.S.
- Laboratory site
- bioviridians.com
- Certificate number
- COA7585
- Lot number
- TA110-0803
- Sample received
- Aug 11, 2026
- Certificate issued
- Aug 28, 2026
- Sample as named on the certificate
- Thymosin Alpha-1 10mg
- Sample type
- White lyophilized powder
- Vendor named on the certificate
- American Peptides
The laboratory tested a sample of this lot submitted by the vendor named above. The certificate is not reproduced on this site; the links go to the original files, unaltered.
Issue history
- Current issue · Aug 28, 2026 · served by bioviridians.comd49f1dca…c3dc65PDF
- Earlier issue · Aug 17, 2026 · as published by the vendor before the laboratory reissued itf3f6bd76…583cd3PDF
Changed in the reissue: Sterility result added. Lot, strength and results are the same in both issues.
The fingerprint (SHA-256) identifies the exact file we read on Sep 24, 2026. If the laboratory changes the file, the fingerprint changes and the next check flags it.
See Thymosin alpha-1All certificates
For laboratory research use only. Not a drug, not a supplement, not for human or veterinary use.

